LFST Stock Recent News

SCOTTSDALE, Ariz., May 28, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 46th Annual Goldman Sachs Healthcare Conference, which will be hosted in Miami, Florida.

Live Updates Live Coverage Has Ended Goldman Bullish on Nuclear Stocks 12:05 pm by Gerelyn Terzo Goldman Sachs is bullish on two nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR) – saying they are poised to benefit from the Trump administration’s friendly regulation. Both stocks have rallied by double-digit percentages in recent days. President Trump is determined to bolster domestic uranium production, send advanced reactors to military and energy sites, and tighten the window for new reactor license approvals to 18 months, a process that traditionally is infamous for being extremely lengthy. The markets are holding their gains, including a 2.1% advance in the Nasdaq Composite. Consumer Confidence Soars 10:35 am by Gerelyn Terzo Consumer Confidence surged in May, hitting 98 – a significant 12.3-point jump from April. This robust reading defied economists’ predictions of 86, despite ongoing tariff concerns. The markets are widening their lead,

Live Updates Live Coverage Has Ended Wall Street Endorses Nuclear Stocks 12:10 pm by Gerelyn Terzo Goldman Sachs has issued a bullish report on a pair of nuclear stocks – Cameco (NYSE: CCJ) and NuScale Power (NYSE: SMR) – pointing to regulatory tailwinds from the Trump administration. Both stocks have risen by double-digit percentages since President Trump issued an executive order last week. The president is determined to bolster domestic uranium production, send advanced reactors to military and energy sites, and shorten the wait for new reactor license approvals to one and a half years, a process that historically is known for moving at a snail’s pace. Business Orders Soften 10:30 am by Gerelyn Terzo Durable goods orders posted a 6.3% decline last month, a softer drop than economists had predicted. However, this dip follows four consecutive months of increases, painting a mixed picture for business spending amid ongoing tariff discussions. A significant drag on the overall

SCOTTSDALE, Ariz. , May 14, 2025 /PRNewswire/ -- LifeStance Health, one of the nation's largest providers of virtual and in-person outpatient mental health care, today announced that Vaughn Paunovich will join the company as Chief Technology Officer, effective Monday, June 9, 2025.

LifeStance Health Group, Inc. (NASDAQ:LFST ) Q1 2025 Results Conference Call May 7, 2025 8:30 AM ET Company Participants Monica Prokocki - VP, IR Ryan McGroarty - CFO David Bourdon - CEO Conference Call Participants Craig Hettenbach - Morgan Stanley Jamie Perse - Goldman Sachs Ryan Daniels - William Blair Brian Tanquilut - Jefferies Richard Close - Canaccord Genuity Dylan Christopher - UBS Steven Dechert - KeyBanc Capital Markets Operator Good day, everyone, and thank you for standing by. My name is Arji, and I will be your conference operator today.

LifeStance Health (LFST) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

LifeStance Health (LFST) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

LifeStance Health Group (LFST) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.04. This compares to loss of $0.06 per share a year ago.

SCOTTSDALE, Ariz., May 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results for the first quarter ended March 31, 2025.

The mean of analysts' price targets for LifeStance Health (LFST) points to a 28.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.